[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Redeye_ Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::153838561.png) @Redeye_ Redeye

Redeye posts on X about $geno, $ver, geno, $vit the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::153838561/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153838561/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXXXX -XXXX%

### Mentions: XX [#](/creator/twitter::153838561/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153838561/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +24%
- X Year XXXXX +40%

### Followers: XXXXXX [#](/creator/twitter::153838561/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153838561/c:line/m:followers.svg)

- X Week XXXXXX +0.10%
- X Month XXXXXX +0.13%
- X Months XXXXXX -XXXX%
- X Year XXXXXX -XXXX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::153838561/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153838561/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::153838561/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX% [finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[$geno](/topic/$geno) #1, [$ver](/topic/$ver) #7, [geno](/topic/geno) 0.94%, [$vit](/topic/$vit) #2, [upside](/topic/upside) 0.47%, [$lime](/topic/$lime) 0.47%, [balanced](/topic/balanced) 0.47%, [longterm](/topic/longterm) 0.47%, [$dvysr](/topic/$dvysr) 0.47%, [acquisition](/topic/acquisition) XXXX%

**Top accounts mentioned or mentioned by**
[@longriver_hk](/creator/undefined) [@safelloab](/creator/undefined) [@taocat_agent](/creator/undefined) [@10_ch_10](/creator/undefined) [@tomasotterbeck](/creator/undefined) [@thome_fole](/creator/undefined) [@fredrikkjell](/creator/undefined)

**Top assets mentioned**
[GenomeFi (GENO)](/topic/$geno) [Team Vitality Fan Token (VIT)](/topic/$vit) [iMe Lab (LIME)](/topic/$lime) [Deere & Company (DE)](/topic/$de) [Biconomy (BICO)](/topic/$bico)
### Top Social Posts [#](/creator/twitter::153838561/posts)
---
Top posts by engagements in the last XX hours

"Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER"  
[X Link](https://x.com/Redeye_/status/1970009407556649224) [@Redeye_](/creator/x/Redeye_) 2025-09-22T06:16Z 14.5K followers, 1417 engagements


"Redeye retains its SEK394 Base Case in Lime leaving notable upside potential given the recent soft share price performance. $LIME"  
[X Link](https://x.com/Redeye_/status/1973678475656806413) [@Redeye_](/creator/x/Redeye_) 2025-10-02T09:16Z 14.5K followers, XXX engagements


"Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO"  
[X Link](https://x.com/Redeye_/status/1955189857602469971) [@Redeye_](/creator/x/Redeye_) 2025-08-12T08:49Z 14.5K followers, 1010 engagements


"Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO"  
[X Link](https://x.com/Redeye_/status/1955529686043501021) [@Redeye_](/creator/x/Redeye_) 2025-08-13T07:19Z 14.5K followers, 1140 engagements


"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"  
[X Link](https://x.com/Redeye_/status/1940346251234640071) [@Redeye_](/creator/x/Redeye_) 2025-07-02T09:46Z 14.5K followers, 1449 engagements


"Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR"  
[X Link](https://x.com/Redeye_/status/1961072328944636250) [@Redeye_](/creator/x/Redeye_) 2025-08-28T14:24Z 14.5K followers, 1215 engagements


"Redeye comments on Verve's announced acquisition. $VER"  
[X Link](https://x.com/Redeye_/status/1968331752470097950) [@Redeye_](/creator/x/Redeye_) 2025-09-17T15:10Z 14.5K followers, 1335 engagements


"Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE"  
[X Link](https://x.com/Redeye_/status/1978381140831457496) [@Redeye_](/creator/x/Redeye_) 2025-10-15T08:43Z 14.5K followers, XXX engagements


"Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX"  
[X Link](https://x.com/Redeye_/status/1978738980804825380) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:25Z 14.5K followers, 1036 engagements


"BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO"  
[X Link](https://x.com/Redeye_/status/1975477431659340000) [@Redeye_](/creator/x/Redeye_) 2025-10-07T08:24Z 14.5K followers, 1159 engagements


"Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT"  
[X Link](https://x.com/Redeye_/status/1978738525576024436) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:23Z 14.5K followers, XXX engagements


"Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT"  
[X Link](https://x.com/Redeye_/status/1979058100423291260) [@Redeye_](/creator/x/Redeye_) 2025-10-17T05:33Z 14.5K followers, XXX engagements


"Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER"  
[X Link](https://x.com/Redeye_/status/1956252758702432763) [@Redeye_](/creator/x/Redeye_) 2025-08-15T07:12Z 14.5K followers, 1794 engagements


"Redeye notes an interesting press release from Genovis confirming a SEK11m order from a global pharmaceutical company. $GENO"  
[X Link](https://x.com/Redeye_/status/1980136900909584869) [@Redeye_](/creator/x/Redeye_) 2025-10-20T05:00Z 14.5K followers, XXX engagements


"Redeye updates its estimates and valuation after Indutrades Q2 2025 report. $INDT"  
[X Link](https://x.com/Redeye_/status/1945349912696156366) [@Redeye_](/creator/x/Redeye_) 2025-07-16T05:08Z 14.5K followers, 1291 engagements


"Redeye is positive about the acceptance of Paxmans PLCS system for CIPN into the FDAs Safer Technologies Program (SteP). $PAX"  
[X Link](https://x.com/Redeye_/status/1980165309513507297) [@Redeye_](/creator/x/Redeye_) 2025-10-20T06:52Z 14.5K followers, XXX engagements